Treatment of pulmonary arterial hypertension with mesenchymal stem cells

摘要

The present application is a method of treating or preventing vascular disorders, comprising administering to a subject in need thereof a pharmaceutical composition comprising mesenchymal progenitor cells (MPC) and prostacyclin. is connected with. A method for treating or preventing vascular disorders in a subject in need thereof, comprising administering to said subject prostacyclin and mesenchymal stem cells (MSC) or MSC conditioned culture medium, or Also provided is a method comprising administering to the subject MSC or MSC conditioned culture medium treated with prostacyclin. Pharmaceutical compositions suitable for such treatment are also provided.